SLC37A4 and central nervous system cancer: The knockdown of G6PC3 and SLC37A4 in neurospheres resulted in a significant reduction in the expression levels of CSC markers, including EMT biomarkers, all collectively associated with stemness, self-renewal capacity, and invasive properties of glioma stem cells (49).